DynaMed Systems

DynaMed Systems is a medical technology company specializing in the development of regenerative neurostimulation devices for the treatment of spinal cord injuries and neuromotor impairments. The company's flagship technology, the Traxon Spinal Cord Repair Stimulation System, utilizes oriented and linear electrical fields to promote the organized growth and regeneration of damaged nerve fibers in the central and peripheral nervous systems. DynaMed Systems received FDA approval for an Investigational Device Exemption (IDE) in 2008 to conduct pilot clinical studies in the United States, following successful early-stage research in the United Kingdom. The company's proprietary approach aims to restore motor function and accelerate tissue healing by facilitating cellular migration into injured areas. Recent patent activity suggests ongoing development in the field of closed-loop and open-loop neuromodulation systems.